All Updates

WASHINGTON, D.C. – Yesterday, the U.S. Department of Health and Human Services (HHS) announced coordinated efforts across multiple agencies within the department to accelerate development of clinical research and remove barriers to clinical trial participation. As part of this initiative, the HHS Office of Inspector General (OIG) is

The American Cancer Society Cancer Action Network (ACS CAN) applauds Gov. Katie Hobbs for signing a bill to improve access and remove financial barriers to lifesaving breast cancer screenings. SB1165, which passed with significant bipartisan majorities in both chambers of the state Legislature, will ensure the full continuum of medically

Today, legislation aiming to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans, was voted out of committee and will soon be heard by the full House. This marks the final step before the bill goes to Governor Matt Meyer who, earlier this year, identified biomarker testing access as a priority.

HELENA, Mont. -- Cigarette use continues to take a heavy toll in Montana, claiming about 1,600 lives each year. Against this backdrop, a new statewide poll finds broad support across political parties for proven policies that can prevent tobacco use and save lives. The poll shows 77% of Montana voters

California lawmakers adopted a state budget that eliminates $2.98 million in funding for regional contractors in the Every Woman Counts (EWC) program, which provides breast and cervical cancer screening and diagnostic services at no cost to uninsured or underinsured Californians.

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) applauding provisions of the 2026 Interoperability Standards and Prior Authorization for Drugs

SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases. The American Cancer Society Cancer Action Network (ACS CAN) and its Oregon partners will advocate for expanded access during the 2027 Oregon Legislature and

DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, providing

Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).